Annotated Medicine and Device Lists

Lopinavir + ritonavir (LPV/r)

Capsule 133.3 mg + 33.3 mg Oral liquid 400 mg + 100 mg/5 ml Oral liquid 80 + 20 mg/ml Solid oral dosage form 40 mg + 10 mg Tablet (heat stable) 100 mg + 25 mg Tablet (heat stable) 200 mg + 50 mg

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Peru	6.4.2.3 Protease Inhibitors	No observations

This medicine is present in:

List	Section	Observation
PAHO Strategic Fund Medicine List	2.6.1. Antiretrovirals	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.2.3. Protease inhibitors	This medicine is only for children.
PAHO Strategic Fund Medicine List	2.6.1. Antiretrovirals	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.2.3. Protease inhibitors	No observations
PAHO Strategic Fund Medicine List	2.6.1. Antiretrovirals	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.2.3. Protease inhibitors	No observations
PAHO Strategic Fund Medicine List	2.6.1. Antiretrovirals	No observations
Peru	6.4.2.3 Protease Inhibitors	No observations

Information Resources: Lopinavir + ritonavir (LPV/r)

No information available